1102. COVID-19 and the Risk of CNS Demyelinating Diseases

For this episode of “Ask the Expert: Research Edition,” Rebecca
Whitney of SRNA was joined by Dr. Michael Levy. Dr. Levy gave a
brief overview of one of his recent papers with colleagues that
was featured in Frontiers in Neurology, “COVID-19 and the risk of
CNS demyelinating diseases: A systematic review.” For this paper,
the authors reviewed literature published in English on different
platforms around the world where the diagnosis was confirmed
usually with aquaporin-4 or MOG antibody testing, including
children and adults. They examined whether Covid infections cause
inflammatory central nervous system (CNS) demyelinating diseases,
including multiple sclerosis, NMOSD, MOG antibody disease, or
relapses, and at what rate. You can view the paper here:
https://www.frontiersin.org/articles/10.3389/fneur.2022.970383/full